SkinHealth Systems Inc. cash flow to debt ratio of 9.90% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

SkinHealth Systems Inc.'s free cash flow has increased 298.09% from $9.34M last year to $37.18M, signaling increasing performance

SkinHealth Systems Inc.'s debt to equity ratio is 6.60, which means that the company's assets are unhealthy financed, signaling financial risk.

SkinHealth Systems Inc.'s debt has decreased relative to shareholder equity from 10.97 last year to 6.60 today, signaling strengthened financials

SkinHealth Systems Inc. has a net debt to EBITDA ratio of 3.77x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

SkinHealth Systems Inc.'s interest coverage ratio is -0.17, which means that the company struggles to meet interest obligations, signaling financial risk.

SkinHealth Systems Inc.'s profit margin has decreased (12.51%) in the last year from -8.70% to -9.79%, signaling decreasing performance

SkinHealth Systems Inc.'s short-term assets of $309.50M exceed its short-term liabilities of $186.30M

SkinHealth Systems Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

SkinHealth Systems Inc.'s return on equity of -47.84%, is lower than 15.00%, indicating bad performance

SkinHealth Systems Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

SkinHealth Systems Inc. had positive net income in only 1 out of 5 years, indicating unstable earnings

SkinHealth Systems Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

SkinHealth Systems Inc. has a free cash flow yield of 44.83%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

SkinHealth Systems Inc.'s yearly earnings has increased -67.29% since last year from $-29.10M to $-9.52M, signaling increasing performance

SkinHealth Systems Inc.'s yearly revenue has decreased 10.02% since last year from $334.29M to $300.80M, signaling decreasing performance

ROIC -1.01% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

SkinHealth Systems Inc.'s 3-year revenue CAGR of -6.32% is negative, indicating declining revenue over the past 3 years

SkinHealth Systems Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

SkinHealth Systems Inc. had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity

SkinHealth Systems Inc. has insufficient data to evaluate this check.

SkinHealth Systems Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

SkinHealth Systems Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

SkinHealth Systems Inc. has an EV/EBITDA ratio of 5.91x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

SkinHealth Systems Inc. has insufficient data to evaluate this check.

SkinHealth Systems Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

SkinHealth Systems Inc. has a price-to-book ratio of 1.49x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

SkinHealth Systems Inc. has a price-to-sales ratio of 0.29x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue